David Szwajcer

1.8k total citations
40 papers, 863 citations indexed

About

David Szwajcer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, David Szwajcer has authored 40 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Oncology. Recurrent topics in David Szwajcer's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (11 papers) and Lymphoma Diagnosis and Treatment (6 papers). David Szwajcer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (11 papers) and Lymphoma Diagnosis and Treatment (6 papers). David Szwajcer collaborates with scholars based in Canada, United States and Australia. David Szwajcer's co-authors include Stephen Couban, Stephanie J. Lee, John Kuruvilla, Holly Kerr, Thomas J. Nevill, Geneviève Gallagher, Jean Roy, Félix Couture, Tony Panzarella and Simon A. Hill and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

David Szwajcer

39 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Szwajcer Canada	15	490	257	219	160	107	40	863
H T Kim United States	10	279 0.6×	170 0.7×	100 0.5×	251 1.6×	103 1.0×	11	670
Annie Im United States	13	403 0.8×	301 1.2×	116 0.5×	231 1.4×	139 1.3×	64	851
R Powles United Kingdom	19	645 1.3×	258 1.0×	310 1.4×	228 1.4×	124 1.2×	52	1.1k
David Topolsky United States	15	337 0.7×	348 1.4×	96 0.4×	86 0.5×	93 0.9×	39	884
Elisabetta Todisco Italy	19	410 0.8×	487 1.9×	90 0.4×	257 1.6×	151 1.4×	56	1.1k
Deepesh Lad India	14	265 0.5×	153 0.6×	82 0.4×	140 0.9×	202 1.9×	131	622
Angela C. Weyand United States	17	906 1.8×	92 0.4×	94 0.4×	178 1.1×	226 2.1×	69	1.3k
S.J. Proctor United Kingdom	17	344 0.7×	333 1.3×	225 1.0×	158 1.0×	111 1.0×	44	967
Roman M. Shapiro United States	14	195 0.4×	156 0.6×	79 0.4×	171 1.1×	48 0.4×	46	497
Alexandra M. Harrington United States	17	227 0.5×	361 1.4×	73 0.3×	126 0.8×	149 1.4×	64	1.0k

Countries citing papers authored by David Szwajcer

Since Specialization

Citations

This map shows the geographic impact of David Szwajcer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Szwajcer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Szwajcer more than expected).

Fields of papers citing papers by David Szwajcer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Szwajcer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Szwajcer. The network helps show where David Szwajcer may publish in the future.

Co-authorship network of co-authors of David Szwajcer

This figure shows the co-authorship network connecting the top 25 collaborators of David Szwajcer. A scholar is included among the top collaborators of David Szwajcer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Szwajcer. David Szwajcer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berard, Jason A., Mark S. Freedman, Ruth Ann Marrie, et al.. (2022). Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial. Multiple Sclerosis and Related Disorders. 61. 103779–103779. 4 indexed citations

Ahmad, Imran, Janet J. Bijl, Sabine Ivison, et al.. (2021). Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid- Refractory or Dependent Chronic GVHD – a Multicentre Phase II Clinical Trial (CARE Trial). Transplantation and Cellular Therapy. 27(3). S285–S285. 1 indexed citations

Lee-Wing, Matthew, et al.. (2020). Manufacturing autologous myoblast for regenerative medicine applications. Cytotechnology. 72(5). 605–614. 3 indexed citations

Guan, Qingdong, Xun Wu, Versha Banerji, et al.. (2019). Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow. British Journal of Haematology. 185(5). 883–887. 5 indexed citations

Rae, Charlene, Jason D. Pole, Sumit Gupta, et al.. (2019). Development of System Performance Indicators for Adolescent and Young Adult Cancer Care and Control in Canada. Value in Health. 23(1). 74–88. 16 indexed citations

Perry, Anamarija M., Philip J. Bierman, Fausto R. Loberiza, et al.. (2017). Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma. Neuropathology. 37(6). 509–516. 32 indexed citations

Ramphal, Raveena, Piotr Czaykowski, Sonja De Pauw, et al.. (2016). Adolescent and Young Adult Cancer: Principles of Care. Current Oncology. 23(3). 204–209. 23 indexed citations

Baetz, Tara, Bingshu E. Chen, Stephen Couban, et al.. (2016). Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^*. Leukemia & lymphoma. 58(1). 64–69. 8 indexed citations

Walker, Irwin, Tony Panzarella, Stephen Couban, et al.. (2015). Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. The Lancet Oncology. 17(2). 164–173. 236 indexed citations

10.

Wood, William A., Stephanie J. Lee, Ruta Brazauskas, et al.. (2014). Survival Improvements in Adolescents and Young Adults after Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 20(6). 829–836. 33 indexed citations

11.

Törlén, Johan, Olle Ringdén, Jennifer Le Rademacher, et al.. (2014). Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(9). 1418–1425. 34 indexed citations

12.

Ballen, Karen K., Steven Joffe, Ruta Brazauskas, et al.. (2014). Hospital Length of Stay in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources. Biology of Blood and Marrow Transplantation. 20(11). 1819–1827. 32 indexed citations

13.

Szwajcer, David, Ganchimeg Ishdorj, Wenyan Xiao, et al.. (2013). Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B. Blood Cancer Journal. 3(10). e153–e153. 16 indexed citations

14.

Szwajcer, David, Piotr Czaykowski, & Donna Turner. (2011). Assessment and Management of Febrile Neutropenia in Emergency Departments within a Regional Health Authority—A Benchmark Analysis. Current Oncology. 18(6). 280–284. 35 indexed citations

15.

Paulson, Kristjan, et al.. (2011). The role of allogeneic stem cell transplantation for adult acute lymphoblastic leukemia. Transfusion and Apheresis Science. 44(2). 197–203. 9 indexed citations

16.

Kumar, Rajat, Kristjan Paulson, David Szwajcer, et al.. (2011). Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) is Underutilized in Myelodysplastic Syndrome (MDS): a Population-Based Canadian Province Experience. Biology of Blood and Marrow Transplantation. 17(2). S294–S294. 1 indexed citations

17.

Yoon, Ju‐Yoon, et al.. (2010). Effect of Valproic Acid (VPA) on Fludarabine Activity In Chronic Lymphocytic Leukemia (CLL) Patients. Blood. 116(21). 4626–4626. 1 indexed citations

18.

Reece, Donna, Andrew R. Belch, David Szwajcer, et al.. (2010). Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT. Blood. 116(21). 1968–1968. 2 indexed citations

19.

Guilfoyle, Regan, A Demers, Christopher Bredeson, et al.. (2008). Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center. Bone Marrow Transplantation. 43(2). 133–139. 64 indexed citations

20.

Ho, M., Deepak Pruthi, Morel Rubinger, et al.. (2007). High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation. Bone Marrow Transplantation. 40(11). 1049–1053. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact